Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

NCT00344370 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus
Dyslipidemia

Interventions

DRUG: Pitavastatin
DRUG: Atorvastatin

Sponsor

Kowa Research Europe